Enrichment
Ozempic (semaglutide) injection for Type 2 Diabetes
Ozempic (semaglutide) injection for Type 2 Diabetes is a company.
FilterKey facts
- country: United States
- Sector: Health Care
- Stack: Google Analytics
Latest news (see all)
Amgen teased trial results for its potential Ozempic competitor -- and the stock surged 13%
Read: Quartz
2024-05-03
Ozempic maker bringing weight-loss drug Wegovy to Canada starting next week
Read: The Star
2024-05-02
Ozempic is so hot right now that subsidies for the drug are being cut in Novo Nordisk's home country
Read: Quartz
2024-05-01
Ozempic among 'bogus' drug patents being challenged by U.S. to spur competition
Read: Global News
2024-04-30
Ozempic and 19 other drugs have 'junk' patents, the FTC says in a new challenge
Read: Quartz
2024-04-30
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Read: CNBC News
2024-04-30
Visualizations
Datasets
Companies in the United States
Companies where Sector equals Health Care
Stocks for Ozempic (semaglutide) injection for Type 2 Diabetes
Source
This dashboard is based on data from: Twitter, YAHOO-FIN, YFINANCE
Updated: 6 days ago
License
This content can be used under the CC BY 4.0 license
